Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Antibody-Drug Conjugates (ADCs)
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (1)
TargetMol | Tags By Application
  • ELISA
    (1)
  • FACS
    (1)
  • Functional assay
    (1)
Filter
Search Result
Results for "

farletuzumab ecteribulin

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    1
    TargetMol | All_Pathways
  • Inhibitory Antibodies
    1
    TargetMol | Inhibitory_Antibodies
  • ADC/ADC Related
    1
    TargetMol | All_Pathways
Farletuzumab ecteribulin
MORAb-202, MORAb202, MORAb 202
T779082407465-18-1
Farletuzumab ecteribulin is an antibody-drug conjugate (ADC) consisting of the humanized antibody farletuzumab, which targets the folate receptor alpha (FRA), with an antibody-to-drug ratio of 4.0. In vitro, farletuzumab ecteribulin exhibits cytotoxic and antitumor activity against FRA-positive cells.
  • $958
6-8 weeks
Size
QTY